Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
D000293:Adolescent; D002648:Child; D002746:Chlorpromazine / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004422:Dystonia Musculorum Deformans / Q000175:diagnosis; D005260:Female; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced* / Q000175:diagnosis; D010300:Parkinson Disease / Q000175:diagnosis; D010640:Phenothiazines / Q000009:adverse effects*; D013881:Thioridazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000009:adverse effects
D010640:Phenothiazines; D014268:Trifluoperazine; D013881:Thioridazine; D002746:Chlorpromazine